Abstract
The association between air pollution and multiple sclerosis (MS) is not entirely clear. This meta-analysis was aimed at determining the correlation between particulate matter (PM)2.5, PM10, and MS incidence/relapse. The literature search was performed in EMBASE, Web of Science, PubMed, and the gray literature. Sixteen articles were retrieved, and ten articles were included and evaluated. Three measures of association were used for the meta-analysis: odds ratio (cross-sectional and case-control studies), incidence rate ratio, or hazard ratio (cohort studies). Meta-analysis of those 3 studies on PM2.5 indicated that exposure to PM2.5 was associated with MS relapse and incidence ([95% confidence interval; CI] 1.178 [1.102, 1.279]), p > 0.05. Also, assessment of risk ratio for all studies showed a correlation between PMs (PM10 and PM2.5) and MS incidence and relapse ([95% CI] 1.28, [1.13–1.43]) p < 0.05. Collectively, we found that PM exposure (PM10 and PM2.5) in MS patients associates with the occurrence and relapse of disease.
Journal Section:
Meta-Analysis
References
1.
Dutta
R
, Trapp
BD
. Pathogenesis of axonal and neuronal damage in multiple sclerosis
. Neurology
. 2007
;68
(22 Suppl 3
):S22
–54
.2.
McKay
KA
, Jahanfar
S
, Duggan
T
, Tkachuk
S
, Tremlett
H
. Factors associated with onset, relapses or progression in multiple sclerosis: a systematic review
. Neurotoxicology
. 2017
;61
:189
–212
.3.
Ritz
SA
. Air pollution as a potential contributor to the “epidemic” of autoimmune disease
. Med Hypotheses
. 2010
;74
(1
):110
–7
.4.
Oikonen
M
, Laaksonen
M
, Laippala
P
, Oksaranta
O
, Lilius
EM
, Lindgren
S
, . Ambient air quality and occurrence of multiple sclerosis relapse
. Neuroepidemiology
. 2003
;22
(1
):95
–9
.5.
Ashtari
F
, Esmaeil
N
, Mansourian
M
, Poursafa
P
, Mirmosayyeb
O
, Barzegar
M
, . An 8-year study of people with multiple sclerosis in Isfahan, Iran: association between environmental air pollutants and severity of disease
. J Neuroimmunol
. 2018
;319
:106
–11
.6.
Palacios
N
, Munger
KL
, Fitzgerald
KC
, Hart
JE
, Chitnis
T
, Ascherio
A
, . Exposure to particulate matter air pollution and risk of multiple sclerosis in two large cohorts of US nurses
. Environ Int
. 2017
;109
:64
–72
.7.
Brook
RD
, Rajagopalan
S
, Pope
CA
, Brook
JR
, Bhatnagar
A
, Diez-Roux
AV
, . Particulate matter air pollution and cardiovascular disease: an update to the scientific statement from the American Heart Association
. Circulation
. 2010
;121
(21
):2331
–78
.8.
Moher
D
, Liberati
A
, Tetzlaff
J
, Altman
DG
. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
. J Clin Epidemiol
. 2009
;62
(10
):1006
–12
.9.
DerSimonian
R
, Laird
N
. Meta-analysis in clinical trials
. Control Clin Trials
. 1986
;7
(3
):177
–88
.10.
Higgins
JP
, Thompson
SG
. Quantifying heterogeneity in a meta-analysis
. Stat Med
. 2002
;21
(11
):1539
–58
.11.
Egger
M
, Davey Smith
G
, Schneider
M
, Minder
C
. Bias in meta-analysis detected by a simple, graphical test
. BMJ
. 1997
;315
(7109
):629
–34
.12.
Egger
MSG
, Altman
DG
. Systematic reviews in health care: meta-analysis in context
. London
: BMJ Publishing Group
; 2001
.13.
Sutton
AJ
, Duval
SJ
, Tweedie
RL
, Abrams
KR
, Jones
DR
. Empirical assessment of effect of publication bias on meta-analyses
. BMJ
. 2000
;320
(7249
):1574
–7
.14.
Roux
J
, Bard
D
, Le Pabic
E
, Segala
C
, Reis
J
, Ongagna
JC
, . Air pollution by particulate matter PM10 may trigger multiple sclerosis relapses
. Environ Res
. 2017
;156
:404
–10
.15.
Bergamaschi
R
, Cortese
A
, Pichiecchio
A
, Berzolari
FG
, Borrelli
P
, Mallucci
G
, . Air pollution is associated to the multiple sclerosis inflammatory activity as measured by brain MRI
. Mult Scler
. 2018
;24
(12
):1578
–84
.16.
Lavery
AM
, Waubant
E
, Casper
TC
, Roalstad
S
, Candee
M
, Rose
J
, . Urban air quality and associations with pediatric multiple sclerosis
. Ann Clin Transl Neurol
. 2018
;5
(10
):1146
–53
.17.
Bai
L
, Burnett
RT
, Kwong
JC
, Hystad
P
, van Donkelaar
A
, Brook
JR
, . Long-term exposure to air pollution and the incidence of multiple sclerosis: A population-based cohort study
. Environ Res
. 2018
;166
:437
–43
.18.
Jeanjean
M
, Bind
MA
, Roux
J
, Ongagna
JC
, de Sèze
J
, Bard
D
, . Ozone, NO2 and PM10 are associated with the occurrence of multiple sclerosis relapses. Evidence from seasonal multi-pollutant analyses
. Environ Res
. 2018
;163
:43
–52
.19.
Carmona
R
, Linares
C
, Recio
A
, Ortiz
C
, Díaz
J
. Emergency multiple sclerosis hospital admissions attributable to chemical and acoustic pollution: Madrid (Spain), 2001–2009
. Sci Total Environ
. 2018
;612
:111
–8
.20.
Gregory
AC
2nd, Shendell
DG
, Okosun
IS
, Gieseker
KE
. Multiple Sclerosis disease distribution and potential impact of environmental air pollutants in Georgia
. Sci Total Environ
. 2008
;396
(1
):42
–51
.21.
Angelici
L
, Piola
M
, Cavalleri
T
, Randi
G
, Cortini
F
, Bergamaschi
R
, . Effects of particulate matter exposure on multiple sclerosis hospital admission in Lombardy region, Italy
. Environ Res
. 2016
;145
:68
–73
.22.
Fu
P
, Guo
X
, Cheung
FMH
, Yung
KKL
. The association between PM2.5 exposure and neurological disorders: A systematic review and meta-analysis
. Sci Total Environ
. 2019
;655
:1240
–8
.23.
Cho
CC
, Hsieh
W-Y
, Tsai
C-H
, Chen
C-Y
, Chang
H-F
, Lin
C-S
. In Vitro and In Vivo Experimental Studies of PM2.5 on Disease Progression
. Int J Environ Res Public Health
. 2018
;15
(7
):1380
.http://dx.doi.org/10.3390/ijerph15071380.,24.
Schulze
F
, Gao
X
, Virzonis
D
, Damiati
S
, Schneider
MR
, Kodzius
R
. Air Quality Effects on Human Health and Approaches for Its Assessment through Microfluidic Chips
. Genes
. 2017
;8
(10
).http://dx.doi.org/10.3390/genes8100244.25.
Xing
YF
, Xu
YH
, Shi
MH
, Lian
YX
. The impact of PM2.5 on the human respiratory system
. J Thorac Dis
. 2016
;8
(1
):E69
–74
.26.
Esmaeil Mousavi
S
, Heydarpour
P
, Reis
J
, Amiri
M
, Sahraian
MA
. Multiple sclerosis and air pollution exposure: Mechanisms toward brain autoimmunity
. Med Hypotheses
. 2017
;100
:23
–30
.27.
Block
ML
, Calderon-Garciduenas
L
. Air pollution: mechanisms of neuroinflammation and CNS disease
. Trends Neurosci
. 2009
;32
(9
):506
–16
.28.
Wang
B-R
, Shi
J-Q
, Ge
N-N
, Ou
Z
, Tian
Y-Y
, Jiang
T
, . PM2.5 exposure aggravates oligomeric amyloid beta-induced neuronal injury and promotes NLRP3 inflammasome activation in an in vitro model of Alzheimer’s disease
. J Neuroinflammation
. 2018
;15
(1
):132
.29.
Silveira
C
, Guedes
R
, Maia
D
, Curral
R
, Coelho
R
. Neuropsychiatric symptoms of multiple sclerosis: state of the art
. Psychiatry Investig
. 2019
;16
(12
):877
–88
.30.
Binzer
S
, McKay
KA
, Brenner
P
, Hillert
J
, Manouchehrinia
A
. Disability worsening among persons with multiple sclerosis and depression: a Swedish cohort study
. Neurology
. 2019
;93
(24
):e2216
–23
.31.
Johansson
V
, Lundholm
C
, Hillert
J
, Masterman
T
, Lichtenstein
P
, Landén
M
, . Multiple sclerosis and psychiatric disorders: comorbidity and sibling risk in a nationwide Swedish cohort
. Mult Scler
. 2014
;20
(14
):1881
–91
.32.
Hoang
H
, Laursen
B
, Stenager
EN
, Stenager
E
. Psychiatric co-morbidity in multiple sclerosis: the risk of depression and anxiety before and after MS diagnosis
. Mult Scler
. 2016
;22
(3
):347
–53
.33.
Zhao
Y
, Wang
L
, Liu
H
, Cao
Z
, Su
X
, Cai
J
, . Particulate air pollution exposure and plasma vitamin D levels in pregnant women: a longitudinal cohort study
. J Clin Endocrinol Metab
. 2019
;104
(8
):3320
–6
.34.
Spanier
JA
, Nashold
FE
, Nelson
CD
, Praska
CE
, Hayes
CE
. Vitamin D3-mediated resistance to a multiple sclerosis model disease depends on myeloid cell 1,25-dihydroxyvitamin D3 synthesis and correlates with increased CD4(+) T cell CTLA-4 expression
. J Neuroimmunol
. 2020
;338
:577105
.35.
Amato
MP
, Derfuss
T
, Hemmer
B
, Liblau
R
, Montalban
X
, Soelberg Sørensen
P
, . Environmental modifiable risk factors for multiple sclerosis: report from the 2016 ECTRIMS focused workshop
. Mult Scler
. 2017
.http://dx.doi.org/10.1177/1352458516686847.36.
Smolders
J
, Mimpen
M
, Oechtering
J
, Damoiseaux
J
, van den Ouweland
J
, Hupperts
R
, . Vitamin D3 supplementation and neurofilament light chain in multiple sclerosis
. Acta Neurol Scand
. 2020
;141
(1
):77
–80
.© 2021 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2021
You do not currently have access to this content.
